Characterization of PD-1/PD-L1 immune checkpoint expression in soft tissue sarcomas

Inhibitors of the programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) immune checkpoint system are used for treating various malignancies. However, evidence on their use in soft tissue sarcomas (STS) is limited. This study aimed to retrospectively investigate the relationship between the expr...

Full description

Bibliographic Details
Main Authors: Kazuhiko Hashimoto, Shunji Nishimura, Tomohiko Ito, Masao Akagi
Format: Article
Language:English
Published: PAGEPress Publications 2021-07-01
Series:European Journal of Histochemistry
Subjects:
Online Access:https://www.ejh.it/index.php/ejh/article/view/3203